Latest filing published 13 Dec 2013 for Enanta Pharmaceuticals INC, €153k.
Insider track record
No signal scores available.
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +85.0%Entry US$5.00 · Close at T+365 US$9.25
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Ernst-Guenter Afting: trading record in brief
Ernst-Guenter Afting is a declared insider at 2 companies; the most frequent names are Enanta Pharmaceuticals Inc and Sorrento Therapeutics, Inc. The record holds 9 filings, for trades running from 21 December 2010 to 11 December 2013.
Market trades split into 1 purchase (€38k) and 3 sales (€403k). The net balance comes to €365k on the selling side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. 2013 to date brings no purchases and 3 sales.
The newest entry dates from 13 December 2013: an open-market sale of €192k, in Enanta Pharmaceuticals Inc. The clock since the last published purchase (18 February 2011) now reads 5,743 days. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. Section 16 rules allow two business days to file each Form 4. A sale on its own says little: insiders also sell to pay tax, fund a purchase or diversify. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Ernst-Guenter Afting
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 5,800 shares@ US$36.38Common StockSEC:0000908662-13-000324:0
- 7,100 shares@ US$37.20Common StockSEC:0000908662-13-000324:1
- 2,100 shares@ US$37.92Common StockSEC:0000908662-13-000324:2
- 674 sharesCommon StockSEC:0000908662-13-000163:2
- 2,320 sharesCommon StockSEC:0000908662-13-000163:0
- 2,320 sharesCommon StockSEC:0000908662-13-000163:1
- 97 sharesCommon StockSEC:0000908662-13-000163:3
- 11,215 sharesCommon StockSEC:0000908662-13-000163:4
- 360,000 shares@ US$0.14Common StockSEC:0001181431-11-011587:0Canonical exit: 21 Mar 2011 (T+90)
9 of 9 declarations